Vinva Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.22M Buy
74,634
+42,397
+132% +$2.82M 0.03% 241
2026
Q1
$2M Buy
+32,237
New +$2.24M 0.02% 285
2025
Q3
– Sell
-6,994
Closed -$604K – 436
2025
Q2
$604K Buy
+6,994
New +$548K 0.02% 342
2025
Q1
– Sell
-13,207
Closed -$1.03M – 399
2024
Q4
$1.03M Buy
+13,207
New +$978K 0.04% 288
2024
Q3
– Sell
-10,928
Closed -$1.25M – 428
2024
Q2
$1.25M Sell
10,928
-3,660
-25% -$463K 0.06% 265
2024
Q1
$2.02M Buy
14,588
+7,000
+92% +$880K 0.11% 206
2023
Q4
$942K Sell
7,588
-2,904
-28% -$297K 0.06% 271
2023
Q3
$1M Sell
10,492
-2,359
-18% -$266K 0.09% 220
2023
Q2
$1.64M Buy
12,851
+2,325
+22% +$281K 0.14% 171
2023
Q1
$1.2M Buy
+10,526
New +$1.18M 0.1% 224

Other funds holding DXCM

Vinva Investment Management's DXCM Position: Q2 2026 in Review

Vinva Investment Management increased its DexCom (DXCM) stake by 132% in Q2 2026, buying an estimated $2.82M and bringing the position to 74,634 shares worth $5.22M. The position accounts for 0.03% of the portfolio, ranked #241.

Vinva Investment Management first reported a position in DXCM in Q1 2023 and has held it in 10 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Vinva Investment Management held 74,634 shares of DexCom worth $5.22M as of Q2 2026.
  • Vinva Investment Management bought 42,397 DexCom shares in Q2 2026, an estimated $2.82M.
  • DexCom made up 0.03% of Vinva Investment Management's portfolio in Q2 2026, its #241 holding.
  • Vinva Investment Management first reported a position in DexCom in Q1 2023 and has held it in 10 quarters since.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.